SEVERE WX : Red Flag Warning View Alerts
STREAMING NOW: Watch Now

FDA investigation into heart drug valsartan may lead to more recalls

The ...

Posted: Aug 31, 2018 5:15 AM
Updated: Aug 31, 2018 5:15 AM

The US Food and Drug Administration said Thursday that it is conducting an extensive investigation into an entire class of drugs over potential cancer risk.

The investigation started in July when lab tests determined that some medications containing valsartan, a component in a set of drugs that helps control high blood pressure and reduce the risk of heart failure, were contaminated with a chemical called NDMA. Five manufacturers and other companies that repackage those drugs now have recalled them. On Thursday, the FDA said that more products may need to be recalled depending on the results of its tests.

Business and industry sectors

Business, economy and trade

Company activities and management

Consumer protection

Government organizations - US

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

Product management

Product recalls

Society

US Department of Health and Human Services

US federal departments and agencies

US Food and Drug Administration

Pharmacies and pharmacists

Controlled substances

Crime, law enforcement and corrections

Criminal offenses

Drug crimes

Drugs and society

Investigations

The agency has regularly updated its list of drugs that have been recalled. Because not all versions of drugs containing valsartan are on that list, the agency has published a second list with drugs that are not affected.

N-nitrosodimethylamine, or NDMA, is considered a possible carcinogen by the US Environmental Protection Agency.

It's an organic chemical used to make liquid rocket fuel and a byproduct from manufacturing some pesticides and processing fish. NDMA can also be unintentionally introduced into manufacturing through certain chemical reactions.

On Thursday, a statement from FDA Commissioner Dr. Scott Gottlieb and Dr. Janet Woodcock of the Center for Drug Evaluation and Research the agency is testing more than just drugs containing valsartan: It is looking at "all the products in the ARB class to determine if they contain NDMA."

ARBs, angiotensin II receptor blockers, are drugs that block angiotensin, a potent chemical in your blood that causes muscles surrounding blood vessels to contract, from binding with angiotensin II receptors. When the chemical binds, it narrows the vessels, and that can cause high blood pressure.

Other drugs in this class include losartan, telmisartan, olmesartan, irbesartan, eprosartan, candesartan and azilsartan. None of the drugs are recalled, but the process used to make them can be similar to how valsartan is made, and the FDA wants to make sure that the manufacturing process itself isn't introducing NDMA.

To determine whether the other drugs have problems, scientists at the FDA's lab in St. Louis had to develop a test to detect NDMA and to determine how much of it was in the drugs. The FDA said NDMA's components make it difficult to detect.

Based on the test results, the FDA suspects that the maker of the recalled valsartan, the Chinese company ZHP, changed the way it made the drug, and that may be how it became tainted with NDMA.

"We are still not 100 percent sure that this is the root cause of the problem," the statement said. "Full understanding will require correlation of multiple test results from valsartan [active pharmaceutical ingredients] made by different processes with the various process steps used by different manufacturers or at different times."

Once the FDA determines how the medications came to be tainted, it will make sure that drugs are tested for this impurity in the future.

The FDA is particularly concerned about this issue because, unlike most impurities in drugs, "genotoxic impurities" -- the chemical class that NDMA is in -- have the potential to "cause harm at very low levels."

To get a sense of what taking one of these tainted drugs could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer.

The FDA said it has worked closely with international regulators to set standards to lower the risk of the introduction of these impurities into the drug manufacturing process.

If you take valsartan and are worried about it, the Center for Drug Evaluation and Research offers a toll-free number -- (855) 543-3784 -- that is staffed by pharmacists and nurses. Email inquiries can be sent to druginfo@fda.hhs.gov.

It's also important to talk with your doctor or pharmacist before changing any routine with your medicine. They might be able to switch you to a version made by a company that's not on the recall list.

The FDA also suggests taking the drug you have until your doctor or pharmacist provides a replacement.

"The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July after the first recall was announced. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first."

Oregon Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 32994

Reported Deaths: 547
CountyConfirmedDeaths
Multnomah7204138
Marion469594
Washington454060
Umatilla298741
Clackamas242061
Malheur163327
Lane123417
Jackson11615
Deschutes85212
Yamhill76213
Jefferson5418
Polk53215
Linn52213
Morrow5056
Lincoln48213
Union4462
Benton3146
Wasco2963
Klamath2802
Hood River2520
Douglas2334
Clatsop2170
Josephine1982
Columbia1791
Coos1570
Baker942
Crook621
Tillamook530
Lake330
Curry310
Wallowa311
Sherman180
Harney120
Grant100
Gilliam80
Unassigned00
Wheeler00

California Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 812711

Reported Deaths: 15633
CountyConfirmedDeaths
Los Angeles2684556515
Riverside589321206
San Bernardino54482925
Orange534481216
San Diego46734776
Kern31994369
Fresno28441382
Sacramento22356406
Santa Clara21241314
Alameda21240406
San Joaquin20245441
Contra Costa16640206
Stanislaus16471356
Tulare15970263
Ventura12775150
Imperial11852317
San Francisco11195101
Monterey995372
San Mateo9897150
Santa Barbara9090113
Merced8872142
Kings765180
Sonoma7412122
Marin6730118
Solano640065
Madera453965
Placer358745
San Luis Obispo356229
Butte283344
Yolo281555
Santa Cruz23609
Sutter170511
Napa169013
San Benito134811
Yuba11537
El Dorado11304
Mendocino93418
Shasta88317
Lassen7400
Glenn5783
Tehama5735
Lake55511
Nevada5377
Colusa5316
Humboldt5088
Calaveras31714
Amador29616
Tuolumne2274
Inyo18815
Mono1662
Siskiyou1650
Del Norte1391
Mariposa752
Plumas500
Modoc270
Trinity160
Sierra60
Alpine20
Unassigned00
Medford
Clear
56° wxIcon
Hi: 97° Lo: 55°
Feels Like: 56°
Brookings
Clear
65° wxIcon
Hi: 77° Lo: 59°
Feels Like: 65°
Crater Lake
Clear
42° wxIcon
Hi: 82° Lo: 45°
Feels Like: 39°
Grants Pass
Clear
48° wxIcon
Hi: 97° Lo: 54°
Feels Like: 48°
Klamath Falls
Clear
42° wxIcon
Hi: 85° Lo: 40°
Feels Like: 39°
Hot and dry week, smoke returns
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events

Latest Video

Image

Possible housing solutions after wildfires

Image

Monday, September 28th Evening Weather

Image

Similarities in days had southern Oregonians on edge

Image

Monday, September 28 afternoon weather

Image

Monday, September 28 morning weather

Image

Sunday, September 27 evening weather

Image

Sunday, September 27 morning weather

Image

The initial spread of the Almeda Fire in real-time

Image

Saturday, September 26 evening weather

Image

Saturday, September 26 morning weather